iBio, Inc.IBIONYSE
Loading
Year-over-year SG&A expense growth
Percentile
P29
Within normal range
vs 2Y Ago
-1.4x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -8.43% |
| 2024 | -38.61% |
| 2023 | 5.86% |
| 2022 | -17.93% |
| 2021 | 92.59% |
| 2020 | -7.84% |
| 2019 | 15.41% |
| 2018 | 1.27% |
| 2017 | 37.29% |
| 2016 | 53.03% |